


Ask a doctor about a prescription for INDAPAMIDE RETARD TEVAGEN 1.5 mg PROLONGED-RELEASE TABLETS
Package Leaflet: Information for the User
Indapamide Retard Tevagen 1.5 mg prolonged-release tablets EFG
indapamide
Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.
-Keep this package leaflet, as you may need to read it again.
-If you have any questions, consult your doctor or pharmacist.
-This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
-If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. See section 4.
Contents of the package leaflet:
Indapamide Retard Tevagen is a prolonged-release tablet containing the active substance indapamide.
This medication is used to lower high blood pressure (hypertension) in adults.
Indapamide is a diuretic. Most diuretics increase the amount of urine produced by the kidneys. However, indapamide is different from other diuretics, as it only produces a slight increase in the amount of urine formed.
In addition, indapamide widens blood vessels so that blood can pass through them more easily. This helps to reduce blood pressure.
Do not take Indapamide Retard Tevagen:
Warnings and precautions
Consult your doctor or pharmacist before taking Indapamide Retard Tevagen:
You should inform your doctor if you have had photosensitivity reactions.
Your doctor may prescribe blood tests to check if you have low sodium or potassium levels, or high calcium levels.
If you think any of these situations apply to you or if you have any doubts or questions about taking your medication, you should consult your doctor or pharmacist.
Athletes should be aware that this medication contains an active substance that can produce a positive result in doping tests.
Taking Indapamide Retard Tevagen with other medications
Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medications.
Do not take Indapamide Retard Tevagen in combination with:
Make sure to inform your doctor if you are using any of the following medications, as special care may be required:
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
This medication is not recommended during pregnancy. When pregnancy is planned or confirmed, alternative treatment should be initiated as soon as possible. Inform your doctor if you are pregnant or wish to become pregnant.
The active substance is excreted in breast milk. If you are taking this medication, breastfeeding is not recommended.
Driving and using machines
This medication may cause side effects due to the decrease in blood pressure, causing fatigue or dizziness (see section 4). These side effects are more likely to occur after starting treatment and after increasing the dose. If this happens, you should avoid driving and performing activities that require you to be alert. However, with good control, these side effects are unlikely to occur.
Indapamide Retard Tevagen contains lactose
This medication contains lactose. If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.
Follow the administration instructions of this medication exactly as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The recommended dose is 1.5 mg (one tablet) per day, preferably in the morning.
The tablets can be taken independently of meals. They should be swallowed whole with water. Do not break or chew them.
Treatment for high blood pressure is usually for life.
Patients with kidney problems
Indapamide Retard Tevagen is not recommended for patients with kidney problems.
Patients with liver problems
Indapamide Retard Tevagen is not recommended for patients with liver problems.
Elderly patients
Elderly patients can be treated with Indapamide Retard Tevagen as long as they do not have kidney problems.
Children and adolescents
Indapamide Retard Tevagen is not recommended for use in children and adolescents.
If you take more Indapamide Retard Tevagen than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.
A very high dose of indapamide could cause nausea, vomiting, low blood pressure, cramps, dizziness, drowsiness, confusion, and changes in the amount of urine produced by the kidneys.
If you forget to take Indapamide Retard Tevagen
If you forget to take a dose of this medication, take the next dose at the usual time. Do not take a double dose to make up for forgotten doses.
If you stop taking Indapamide Retard Tevagen
Since treatment for high blood pressure is usually for life, you should talk to your doctor before stopping this medication.
If you have any other questions about the use of this medication, ask your doctor or pharmacist.
Like all medications, this medication can cause side effects, although not everyone gets them.
Stop treatment with this medication and seek immediate medical attention if you experience any of the following serious side effects:
Other side effects may occur, in decreasing order of frequency:
Frequent (may affect up to 1 in 10 patients)
Uncommon (may affect up to 1 in 100 patients)
Rare (may affect up to 1 in 1,000 patients)
Very rare (may affect up to 1 in 10,000 patients)
Not known (cannot be estimated from available data)
Reporting side effects
If you experience any side effects, consult your doctor or pharmacist, even if they are not listed in this package leaflet. You can also report them directly through the Spanish Medicines Agency's website: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not use this medication after the expiration date stated on the packaging and blister after EXP. The expiration date is the last day of the month indicated.
This medication does not require special storage conditions.
Medications should not be disposed of through wastewater or household waste. Return the packaging and any unused medication to the pharmacy's SIGRE point. If in doubt, ask your pharmacist how to dispose of the packaging and medication you no longer need. This will help protect the environment.
Composition of Indapamide Retard Tevagen
Appearance of the product and packaging contents
Indapamide Retard Tevagen are white, round, biconvex tablets, marked with "1.5" on one side and smooth on the other.
Indapamide Retard Tevagen is packaged in blisters of 10, 14, 15, 20, 28, 30, 50, 60, 90, 98, and 100 tablets.
Not all pack sizes may be marketed.
Marketing authorization holder
Teva Pharma, S.L.U.
Anabel Segura 11, Edificio Albatros B, 1st floor.
28108 Alcobendas, Madrid.
Manufacturer
TEVA Pharmaceutical Works Private Limited Company
Pallagi út 13, 4042 Debrecen
Hungary
or
Pharmachemie B.V.
Swensweg 5, 2031 GA Haarlem
Netherlands
This medication is authorized in the Member States of the European Economic Area and in the United Kingdom (Northern Ireland) under the following names:
Denmark: Indapamid Teva
Estonia: Indamax
France: Indapamide TEVA Santé LP 1.5 mg, prolonged-release tablet
Latvia: Indamax 1.5 mg prolonged-release tablets
Lithuania: Indamax 1.5 mg prolonged-release tablets
Portugal: Indapamida Teva
Spain: Indapamida Retard Tevagen 1.5 mg prolonged-release tablets EFG
United Kingdom (NI): CARDIDE SR 1.5 mg Prolonged Release Tablets
Date of last revision of this package leaflet: February 2023
Detailed information about this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) https://www.aemps.gob.es/
You can access detailed and updated information about this medication by scanning the QR code included in the packaging with your smartphone. You can also access this information at the following internet address: https://cima.aemps.es/cima/dochtml/p/74633/P_74633.html
QR code + URL
The average price of INDAPAMIDE RETARD TEVAGEN 1.5 mg PROLONGED-RELEASE TABLETS in November, 2025 is around 2.5 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.
The best alternatives with the same active ingredient and therapeutic effect.
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for INDAPAMIDE RETARD TEVAGEN 1.5 mg PROLONGED-RELEASE TABLETS – subject to medical assessment and local rules.